Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-03-19

AUTHORS

Sudharsan Periyasamy-Thandavan, Suchreet Takhar, Adam Singer, Michael Robert Dohn, William Hutch Jackson, April Eve Welborn, Derek LeRoith, Mario Marrero, Muthusamy Thangaraju, Shuang Huang, Patricia Veronica Schoenlein

ABSTRACT

IntroductionIn this pre-clinical in vitro study conducted in estrogen receptor positive (ER+) breast cancer cells, we have characterized the effects of insulin-like growth factor I (IGF-1) on the cytostatic and cytotoxic action of antiestrogen treatment when used as a single agent or in combination with the antiprogestin mifepristone (MIF). Our goal was to identify new molecular targets to improve the efficacy of hormonal therapy in breast cancer patients that have a poor response to hormonal therapy, in part, due to high circulating levels of unbound insulinIGF-1.MethodsIGF-1-mediated effects on cytostasis and apoptotic cell death were determined with cell counts conducted in the presence and absence of trypan blue; enzyme-linked immunosorbent assays to determine the intracellular levels of cleaved cytokeratin 18, a marker of epithelial cancer cell apoptosis; and immunoblot analysis to determine the levels of cleaved poly-ADP ribose polymerase (PARP) and lamin A that result from caspase-dependent apoptosis. Cytotoxicity was further characterized by determination of the levels of reactive oxygen species (ROS) and the percent of mitochondrial membrane depolarization in cell populations treated with the different hormones in the presence and absence of IGF-1. Small molecule inhibitors of the dual-specificity protein kinase MEK1, MEK1 siRNA, Bim siRNA, and vectors overexpressing MEK1 wild type and mutant, dominant negative cDNA were used to identify key IGF-1 downstream prosurvival effectors.ResultsIGF-1, at physiologically relevant levels, blocked the cytotoxic action(s) of the antiestrogens 4-hydroxytamoxifen (4-OHT) and tamoxifen (TAM) when used as single agents or in combination with the antiprogestin MIF. The antiapoptotic action of IGF-1 was mediated primarily through the action of MEK1. MEK1 expression reduced the levels of ROS and mitochondrial membrane depolarization induced by the hormonal treatments via a mechanism that involved the phosphorylation and proteasomal turnover of the proapoptotic BH3-only Bcl-2 family member Bim. Importantly, small-molecule inhibitors of MEK1 circumvented the prosurvival action of IGF-1 by restoring Bim to levels that more effectively mediated apoptosis in ER+ breast cancer cells.Conclusionhis study provides strong support for the use of MEK1 inhibitors in combination with hormonal therapy to effectively affect cytostasis and activate a Bim-dependent apoptotic pathway in ER+ breast cancer cells. We discuss that MEK1 blockade may be a particularly effective treatment for women with high circulating levels of IGF-1, which have been correlated to a poor prognosis. More... »

PAGES

r52

References to SciGraph publications

  • 2005-09. Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival in BREAST CANCER RESEARCH AND TREATMENT
  • 1998-09. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells in BREAST CANCER RESEARCH AND TREATMENT
  • 2008-10-10. Tumour cell survival signalling by the ERK1/2 pathway in CELL DEATH & DIFFERENTIATION
  • 2011-03-07. Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer in ONCOGENE
  • 2001-11-15. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1 in ONCOGENE
  • 2011-10-21. The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study in BREAST CANCER RESEARCH
  • 2002-08. A Novel High-Through-Put Assay for Screening of Pro-Apoptotic Drugs in INVESTIGATIONAL NEW DRUGS
  • 2009-09-01. Biological determinants of endocrine resistance in breast cancer in NATURE REVIEWS CANCER
  • 1998-05. Effect of antiprogestins and tamoxifen on growh inhibition of MCF-7 human breast cancer cells in nude mice in BREAST CANCER RESEARCH AND TREATMENT
  • 2002-06-05. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance in ONCOGENE
  • 2007. Estrogen Receptors in Resistance to Hormone Therapy in BREAST CANCER CHEMOSENSITIVITY
  • 2003-02-25. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator in GENE THERAPY
  • 2010-04-30. Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells in CELL DEATH & DIFFERENTIATION
  • 2009-09-29. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development in BREAST CANCER RESEARCH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/bcr3153

    DOI

    http://dx.doi.org/10.1186/bcr3153

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1019064251

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/22429491


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis Regulatory Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bcl-2-Like Protein 11", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Estrogen Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Estrogen Receptor Modulators", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hormone Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin-Like Growth Factor I", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "MAP Kinase Kinase 1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mifepristone", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oxidative Stress", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphorylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reactive Oxygen Species", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Estrogen", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tamoxifen", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Periyasamy-Thandavan", 
            "givenName": "Sudharsan", 
            "id": "sg:person.0774235463.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774235463.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Takhar", 
            "givenName": "Suchreet", 
            "id": "sg:person.016241417173.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016241417173.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Singer", 
            "givenName": "Adam", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA", 
              "id": "http://www.grid.ac/institutes/grid.152326.1", 
              "name": [
                "Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dohn", 
            "givenName": "Michael Robert", 
            "id": "sg:person.0700722655.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700722655.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jackson", 
            "givenName": "William Hutch", 
            "id": "sg:person.01337003046.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337003046.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Welborn", 
            "givenName": "April Eve", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.59734.3c", 
              "name": [
                "Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "LeRoith", 
            "givenName": "Derek", 
            "id": "sg:person.0756555441.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756555441.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marrero", 
            "givenName": "Mario", 
            "id": "sg:person.0655015541.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655015541.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Biochemistry, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
                "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Thangaraju", 
            "givenName": "Muthusamy", 
            "id": "sg:person.013746210127.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013746210127.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Biochemistry, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
                "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Huang", 
            "givenName": "Shuang", 
            "id": "sg:person.0625462470.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625462470.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
                "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schoenlein", 
            "givenName": "Patricia Veronica", 
            "id": "sg:person.01004662215.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004662215.12"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.onc.1205506", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011228248", 
              "https://doi.org/10.1038/sj.onc.1205506"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1204963", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018294528", 
              "https://doi.org/10.1038/sj.onc.1204963"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cdd.2010.41", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042843410", 
              "https://doi.org/10.1038/cdd.2010.41"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-0-387-74039-3_10", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042360122", 
              "https://doi.org/10.1007/978-0-387-74039-3_10"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr2361", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040461259", 
              "https://doi.org/10.1186/bcr2361"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cdd.2008.148", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043432644", 
              "https://doi.org/10.1038/cdd.2008.148"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1016249728664", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042256597", 
              "https://doi.org/10.1023/a:1016249728664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr3040", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044719011", 
              "https://doi.org/10.1186/bcr3040"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2011.36", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011840580", 
              "https://doi.org/10.1038/onc.2011.36"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.gt.3301897", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001467529", 
              "https://doi.org/10.1038/sj.gt.3301897"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc2713", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018166274", 
              "https://doi.org/10.1038/nrc2713"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1006078032287", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047082193", 
              "https://doi.org/10.1023/a:1006078032287"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1006098910000", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035756397", 
              "https://doi.org/10.1023/a:1006098910000"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-005-4794-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035294705", 
              "https://doi.org/10.1007/s10549-005-4794-6"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2012-03-19", 
        "datePublishedReg": "2012-03-19", 
        "description": "IntroductionIn this pre-clinical in vitro study conducted in estrogen receptor positive (ER+) breast cancer cells, we have characterized the effects of insulin-like growth factor I (IGF-1) on the cytostatic and cytotoxic action of antiestrogen treatment when used as a single agent or in combination with the antiprogestin mifepristone (MIF). Our goal was to identify new molecular targets to improve the efficacy of hormonal therapy in breast cancer patients that have a poor response to hormonal therapy, in part, due to high circulating levels of unbound insulinIGF-1.MethodsIGF-1-mediated effects on cytostasis and apoptotic cell death were determined with cell counts conducted in the presence and absence of trypan blue; enzyme-linked immunosorbent assays to determine the intracellular levels of cleaved cytokeratin 18, a marker of epithelial cancer cell apoptosis; and immunoblot analysis to determine the levels of cleaved poly-ADP ribose polymerase (PARP) and lamin A that result from caspase-dependent apoptosis. Cytotoxicity was further characterized by determination of the levels of reactive oxygen species (ROS) and the percent of mitochondrial membrane depolarization in cell populations treated with the different hormones in the presence and absence of IGF-1. Small molecule inhibitors of the dual-specificity protein kinase MEK1, MEK1 siRNA, Bim siRNA, and vectors overexpressing MEK1 wild type and mutant, dominant negative cDNA were used to identify key IGF-1 downstream prosurvival effectors.ResultsIGF-1, at physiologically relevant levels, blocked the cytotoxic action(s) of the antiestrogens 4-hydroxytamoxifen (4-OHT) and tamoxifen (TAM) when used as single agents or in combination with the antiprogestin MIF. The antiapoptotic action of IGF-1 was mediated primarily through the action of MEK1. MEK1 expression reduced the levels of ROS and mitochondrial membrane depolarization induced by the hormonal treatments via a mechanism that involved the phosphorylation and proteasomal turnover of the proapoptotic BH3-only Bcl-2 family member Bim. Importantly, small-molecule inhibitors of MEK1 circumvented the prosurvival action of IGF-1 by restoring Bim to levels that more effectively mediated apoptosis in ER+ breast cancer cells.Conclusionhis study provides strong support for the use of MEK1 inhibitors in combination with hormonal therapy to effectively affect cytostasis and activate a Bim-dependent apoptotic pathway in ER+ breast cancer cells. We discuss that MEK1 blockade may be a particularly effective treatment for women with high circulating levels of IGF-1, which have been correlated to a poor prognosis.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/bcr3153", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2478808", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2472689", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1022375", 
            "issn": [
              "1465-5411", 
              "1465-542X"
            ], 
            "name": "Breast Cancer Research", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "14"
          }
        ], 
        "keywords": [
          "mitochondrial membrane depolarization", 
          "reactive oxygen species", 
          "small molecule inhibitors", 
          "breast cancer cells", 
          "cancer cells", 
          "protein kinase MEK1", 
          "pro-apoptotic protein Bim", 
          "Bcl-2 family member Bim", 
          "caspase-dependent apoptosis", 
          "apoptotic cell death", 
          "hormonal therapy", 
          "IGF-1", 
          "MEK1 regulation", 
          "membrane depolarization", 
          "kinase MEK1", 
          "levels of ROS", 
          "proteasomal turnover", 
          "dominant-negative cDNA", 
          "ADP-ribose polymerase", 
          "cancer cell apoptosis", 
          "protein Bim", 
          "proapoptotic BH3", 
          "MEK1 inhibitor", 
          "antiprogestin mifepristone", 
          "wild type", 
          "new molecular targets", 
          "apoptotic pathway", 
          "MEK1 expression", 
          "cell death", 
          "prosurvival actions", 
          "single agent", 
          "molecule inhibitors", 
          "MEK1", 
          "ribose polymerase", 
          "estrogen receptor-positive breast cancer cells", 
          "insulin-like growth factor I", 
          "positive breast cancer cells", 
          "insulin-like growth factor-1", 
          "immunoblot analysis", 
          "cell apoptosis", 
          "factor 1", 
          "antiapoptotic action", 
          "breast cancer patients", 
          "intracellular levels", 
          "molecular targets", 
          "apoptosis", 
          "oxygen species", 
          "Bim siRNA", 
          "cell populations", 
          "growth factor I", 
          "growth factor-1", 
          "BH3", 
          "enzyme-linked immunosorbent", 
          "cytotoxic action", 
          "different hormones", 
          "ResultsIGF-1", 
          "poor prognosis", 
          "cells", 
          "antiestrogen treatment", 
          "cancer patients", 
          "poor response", 
          "siRNA", 
          "hormonal treatment", 
          "effective treatment", 
          "factor I", 
          "cell count", 
          "inhibitors", 
          "cytokeratin 18", 
          "mifepristone", 
          "trypan blue", 
          "therapy", 
          "cytostasis", 
          "relevant levels", 
          "mutants", 
          "cDNA", 
          "phosphorylation", 
          "polymerase", 
          "tamoxifen", 
          "antiestrogens", 
          "BIM", 
          "species", 
          "treatment", 
          "effectors", 
          "strong support", 
          "regulation", 
          "pathway", 
          "depolarization", 
          "expression", 
          "turnover", 
          "absence", 
          "levels", 
          "patients", 
          "prognosis", 
          "blockade", 
          "agents", 
          "immunosorbent", 
          "cytotoxic", 
          "target", 
          "hormone", 
          "action", 
          "markers", 
          "women", 
          "efficacy", 
          "death", 
          "mechanism", 
          "cytotoxicity", 
          "presence", 
          "population", 
          "study", 
          "count", 
          "vector", 
          "combination", 
          "percent", 
          "effect", 
          "response", 
          "analysis", 
          "types", 
          "use", 
          "blue", 
          "part", 
          "support", 
          "results", 
          "goal", 
          "determination"
        ], 
        "name": "Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim", 
        "pagination": "r52", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1019064251"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/bcr3153"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "22429491"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/bcr3153", 
          "https://app.dimensions.ai/details/publication/pub.1019064251"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:56", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_566.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/bcr3153"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'


     

    This table displays all metadata directly associated to this object as RDF triples.

    412 TRIPLES      21 PREDICATES      185 URIs      162 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/bcr3153 schema:about N014efe8a67c9479da8ffe64e01d64288
    2 N0399d4b71eb74edcab3128818ea15bf0
    3 N2f8a5fb02d964c2a9630923129a25c03
    4 N30bdc0f84cba4e70902fad5972a5e1f2
    5 N386cc22eeec64f67a2267c02b826a3de
    6 N48d85a584084480ea4c9a50a03498a28
    7 N4b017eca6d264ce69221ca95db3bd836
    8 N52f33e9b9c414bb4ac01c8efce4c58fc
    9 N58cbf91a0fda4ab9bbe3e36af6975ffa
    10 N5e41d31c71054ca6a65f1796c70d0461
    11 N7993d5b72b0c4f6d9b6a485043402ce8
    12 N7f12ac2c672e4eaaaf175c261673e465
    13 N83c5c72167ea453a8dc2e6d4518c3e01
    14 N9b05d21a4ab84732868482d95007a38e
    15 Nc5878e6954cb4226aaf276cd63a9954f
    16 Ne476cd7373014555b25617921a52ec49
    17 Nea28c942ca404c33a32d4c8ed6f05095
    18 Nebcf82a9417549dda832bf2091cf9243
    19 Nef0aa7bd70fc48c3bfba5e88a92c0ce4
    20 Nf9b9d950c92441aab637c7ddf83d97c1
    21 Nff8315903ac34cbfada8510730c233ee
    22 anzsrc-for:11
    23 anzsrc-for:1103
    24 anzsrc-for:1112
    25 schema:author N6d58c54a75b343eaa6e053bcd5fa0508
    26 schema:citation sg:pub.10.1007/978-0-387-74039-3_10
    27 sg:pub.10.1007/s10549-005-4794-6
    28 sg:pub.10.1023/a:1006078032287
    29 sg:pub.10.1023/a:1006098910000
    30 sg:pub.10.1023/a:1016249728664
    31 sg:pub.10.1038/cdd.2008.148
    32 sg:pub.10.1038/cdd.2010.41
    33 sg:pub.10.1038/nrc2713
    34 sg:pub.10.1038/onc.2011.36
    35 sg:pub.10.1038/sj.gt.3301897
    36 sg:pub.10.1038/sj.onc.1204963
    37 sg:pub.10.1038/sj.onc.1205506
    38 sg:pub.10.1186/bcr2361
    39 sg:pub.10.1186/bcr3040
    40 schema:datePublished 2012-03-19
    41 schema:datePublishedReg 2012-03-19
    42 schema:description IntroductionIn this pre-clinical in vitro study conducted in estrogen receptor positive (ER+) breast cancer cells, we have characterized the effects of insulin-like growth factor I (IGF-1) on the cytostatic and cytotoxic action of antiestrogen treatment when used as a single agent or in combination with the antiprogestin mifepristone (MIF). Our goal was to identify new molecular targets to improve the efficacy of hormonal therapy in breast cancer patients that have a poor response to hormonal therapy, in part, due to high circulating levels of unbound insulinIGF-1.MethodsIGF-1-mediated effects on cytostasis and apoptotic cell death were determined with cell counts conducted in the presence and absence of trypan blue; enzyme-linked immunosorbent assays to determine the intracellular levels of cleaved cytokeratin 18, a marker of epithelial cancer cell apoptosis; and immunoblot analysis to determine the levels of cleaved poly-ADP ribose polymerase (PARP) and lamin A that result from caspase-dependent apoptosis. Cytotoxicity was further characterized by determination of the levels of reactive oxygen species (ROS) and the percent of mitochondrial membrane depolarization in cell populations treated with the different hormones in the presence and absence of IGF-1. Small molecule inhibitors of the dual-specificity protein kinase MEK1, MEK1 siRNA, Bim siRNA, and vectors overexpressing MEK1 wild type and mutant, dominant negative cDNA were used to identify key IGF-1 downstream prosurvival effectors.ResultsIGF-1, at physiologically relevant levels, blocked the cytotoxic action(s) of the antiestrogens 4-hydroxytamoxifen (4-OHT) and tamoxifen (TAM) when used as single agents or in combination with the antiprogestin MIF. The antiapoptotic action of IGF-1 was mediated primarily through the action of MEK1. MEK1 expression reduced the levels of ROS and mitochondrial membrane depolarization induced by the hormonal treatments via a mechanism that involved the phosphorylation and proteasomal turnover of the proapoptotic BH3-only Bcl-2 family member Bim. Importantly, small-molecule inhibitors of MEK1 circumvented the prosurvival action of IGF-1 by restoring Bim to levels that more effectively mediated apoptosis in ER+ breast cancer cells.Conclusionhis study provides strong support for the use of MEK1 inhibitors in combination with hormonal therapy to effectively affect cytostasis and activate a Bim-dependent apoptotic pathway in ER+ breast cancer cells. We discuss that MEK1 blockade may be a particularly effective treatment for women with high circulating levels of IGF-1, which have been correlated to a poor prognosis.
    43 schema:genre article
    44 schema:isAccessibleForFree true
    45 schema:isPartOf N219466cf3dd940f3ae7c037c9a21926b
    46 N8fa4aa2c7ff24b74997fcef30055b88c
    47 sg:journal.1022375
    48 schema:keywords ADP-ribose polymerase
    49 BH3
    50 BIM
    51 Bcl-2 family member Bim
    52 Bim siRNA
    53 IGF-1
    54 MEK1
    55 MEK1 expression
    56 MEK1 inhibitor
    57 MEK1 regulation
    58 ResultsIGF-1
    59 absence
    60 action
    61 agents
    62 analysis
    63 antiapoptotic action
    64 antiestrogen treatment
    65 antiestrogens
    66 antiprogestin mifepristone
    67 apoptosis
    68 apoptotic cell death
    69 apoptotic pathway
    70 blockade
    71 blue
    72 breast cancer cells
    73 breast cancer patients
    74 cDNA
    75 cancer cell apoptosis
    76 cancer cells
    77 cancer patients
    78 caspase-dependent apoptosis
    79 cell apoptosis
    80 cell count
    81 cell death
    82 cell populations
    83 cells
    84 combination
    85 count
    86 cytokeratin 18
    87 cytostasis
    88 cytotoxic
    89 cytotoxic action
    90 cytotoxicity
    91 death
    92 depolarization
    93 determination
    94 different hormones
    95 dominant-negative cDNA
    96 effect
    97 effective treatment
    98 effectors
    99 efficacy
    100 enzyme-linked immunosorbent
    101 estrogen receptor-positive breast cancer cells
    102 expression
    103 factor 1
    104 factor I
    105 goal
    106 growth factor I
    107 growth factor-1
    108 hormonal therapy
    109 hormonal treatment
    110 hormone
    111 immunoblot analysis
    112 immunosorbent
    113 inhibitors
    114 insulin-like growth factor I
    115 insulin-like growth factor-1
    116 intracellular levels
    117 kinase MEK1
    118 levels
    119 levels of ROS
    120 markers
    121 mechanism
    122 membrane depolarization
    123 mifepristone
    124 mitochondrial membrane depolarization
    125 molecular targets
    126 molecule inhibitors
    127 mutants
    128 new molecular targets
    129 oxygen species
    130 part
    131 pathway
    132 patients
    133 percent
    134 phosphorylation
    135 polymerase
    136 poor prognosis
    137 poor response
    138 population
    139 positive breast cancer cells
    140 presence
    141 pro-apoptotic protein Bim
    142 proapoptotic BH3
    143 prognosis
    144 prosurvival actions
    145 proteasomal turnover
    146 protein Bim
    147 protein kinase MEK1
    148 reactive oxygen species
    149 regulation
    150 relevant levels
    151 response
    152 results
    153 ribose polymerase
    154 siRNA
    155 single agent
    156 small molecule inhibitors
    157 species
    158 strong support
    159 study
    160 support
    161 tamoxifen
    162 target
    163 therapy
    164 treatment
    165 trypan blue
    166 turnover
    167 types
    168 use
    169 vector
    170 wild type
    171 women
    172 schema:name Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim
    173 schema:pagination r52
    174 schema:productId N5cd3a404cfa64c09886de3c85be93f45
    175 N7235cddc59c94f388245e24c26085b85
    176 Nb342bd0d4e7441deac11d075215f9a68
    177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019064251
    178 https://doi.org/10.1186/bcr3153
    179 schema:sdDatePublished 2022-09-02T15:56
    180 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    181 schema:sdPublisher N43df47aee6024b69bff0afd33b2bdd91
    182 schema:url https://doi.org/10.1186/bcr3153
    183 sgo:license sg:explorer/license/
    184 sgo:sdDataset articles
    185 rdf:type schema:ScholarlyArticle
    186 N014efe8a67c9479da8ffe64e01d64288 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Insulin-Like Growth Factor I
    188 rdf:type schema:DefinedTerm
    189 N0399d4b71eb74edcab3128818ea15bf0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Estrogen Antagonists
    191 rdf:type schema:DefinedTerm
    192 N18566e1ec6194b7582f4ccaf7b6dd1ec rdf:first sg:person.01337003046.60
    193 rdf:rest N30a90e12dbbe480590cf6e56a5a64a24
    194 N219466cf3dd940f3ae7c037c9a21926b schema:issueNumber 2
    195 rdf:type schema:PublicationIssue
    196 N232a6bac086e42b18c9d28afeb26aa26 rdf:first sg:person.0756555441.09
    197 rdf:rest Nf0a5250e142247febc046784195eb268
    198 N23f813d1617f4588bd01a7a8c982c797 rdf:first sg:person.016241417173.08
    199 rdf:rest N64ee6366eb6e42189419ab84572cfd5c
    200 N2f8a5fb02d964c2a9630923129a25c03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Reactive Oxygen Species
    202 rdf:type schema:DefinedTerm
    203 N30a90e12dbbe480590cf6e56a5a64a24 rdf:first N30b2dc74246e4bdeaa1bb674f7c67ead
    204 rdf:rest N232a6bac086e42b18c9d28afeb26aa26
    205 N30b2dc74246e4bdeaa1bb674f7c67ead schema:affiliation grid-institutes:grid.410427.4
    206 schema:familyName Welborn
    207 schema:givenName April Eve
    208 rdf:type schema:Person
    209 N30bdc0f84cba4e70902fad5972a5e1f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name Hormone Antagonists
    211 rdf:type schema:DefinedTerm
    212 N372a2591c6284e6ca4dd8f08a543c6d1 rdf:first sg:person.0700722655.45
    213 rdf:rest N18566e1ec6194b7582f4ccaf7b6dd1ec
    214 N386cc22eeec64f67a2267c02b826a3de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Oxidative Stress
    216 rdf:type schema:DefinedTerm
    217 N43df47aee6024b69bff0afd33b2bdd91 schema:name Springer Nature - SN SciGraph project
    218 rdf:type schema:Organization
    219 N48d85a584084480ea4c9a50a03498a28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    220 schema:name Membrane Proteins
    221 rdf:type schema:DefinedTerm
    222 N4b017eca6d264ce69221ca95db3bd836 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    223 schema:name Estrogen Receptor Modulators
    224 rdf:type schema:DefinedTerm
    225 N50cc275f38eb4735a3d03cd5d14f2351 schema:affiliation grid-institutes:grid.410427.4
    226 schema:familyName Singer
    227 schema:givenName Adam
    228 rdf:type schema:Person
    229 N52f33e9b9c414bb4ac01c8efce4c58fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    230 schema:name Tamoxifen
    231 rdf:type schema:DefinedTerm
    232 N58cbf91a0fda4ab9bbe3e36af6975ffa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    233 schema:name Phosphorylation
    234 rdf:type schema:DefinedTerm
    235 N5cd3a404cfa64c09886de3c85be93f45 schema:name doi
    236 schema:value 10.1186/bcr3153
    237 rdf:type schema:PropertyValue
    238 N5e41d31c71054ca6a65f1796c70d0461 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    239 schema:name Bcl-2-Like Protein 11
    240 rdf:type schema:DefinedTerm
    241 N64ee6366eb6e42189419ab84572cfd5c rdf:first N50cc275f38eb4735a3d03cd5d14f2351
    242 rdf:rest N372a2591c6284e6ca4dd8f08a543c6d1
    243 N6d58c54a75b343eaa6e053bcd5fa0508 rdf:first sg:person.0774235463.53
    244 rdf:rest N23f813d1617f4588bd01a7a8c982c797
    245 N7235cddc59c94f388245e24c26085b85 schema:name pubmed_id
    246 schema:value 22429491
    247 rdf:type schema:PropertyValue
    248 N7993d5b72b0c4f6d9b6a485043402ce8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    249 schema:name Cell Line, Tumor
    250 rdf:type schema:DefinedTerm
    251 N7f12ac2c672e4eaaaf175c261673e465 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    252 schema:name Enzyme Inhibitors
    253 rdf:type schema:DefinedTerm
    254 N83c5c72167ea453a8dc2e6d4518c3e01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    255 schema:name Mifepristone
    256 rdf:type schema:DefinedTerm
    257 N8fa4aa2c7ff24b74997fcef30055b88c schema:volumeNumber 14
    258 rdf:type schema:PublicationVolume
    259 N9b05d21a4ab84732868482d95007a38e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    260 schema:name Apoptosis
    261 rdf:type schema:DefinedTerm
    262 Na4cad30005464fd7a4d1a967d5a8cf24 rdf:first sg:person.0625462470.10
    263 rdf:rest Neb517661e19542b0829e6792cc2d0949
    264 Nb342bd0d4e7441deac11d075215f9a68 schema:name dimensions_id
    265 schema:value pub.1019064251
    266 rdf:type schema:PropertyValue
    267 Nc5878e6954cb4226aaf276cd63a9954f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    268 schema:name Receptors, Estrogen
    269 rdf:type schema:DefinedTerm
    270 Ne476cd7373014555b25617921a52ec49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    271 schema:name Female
    272 rdf:type schema:DefinedTerm
    273 Nea28c942ca404c33a32d4c8ed6f05095 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    274 schema:name MAP Kinase Kinase 1
    275 rdf:type schema:DefinedTerm
    276 Neb517661e19542b0829e6792cc2d0949 rdf:first sg:person.01004662215.12
    277 rdf:rest rdf:nil
    278 Nebcf82a9417549dda832bf2091cf9243 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    279 schema:name Humans
    280 rdf:type schema:DefinedTerm
    281 Nef0aa7bd70fc48c3bfba5e88a92c0ce4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    282 schema:name Proto-Oncogene Proteins
    283 rdf:type schema:DefinedTerm
    284 Nf0a5250e142247febc046784195eb268 rdf:first sg:person.0655015541.06
    285 rdf:rest Nf421506a496344dd84b4e7f571934d0e
    286 Nf421506a496344dd84b4e7f571934d0e rdf:first sg:person.013746210127.32
    287 rdf:rest Na4cad30005464fd7a4d1a967d5a8cf24
    288 Nf9b9d950c92441aab637c7ddf83d97c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    289 schema:name Breast Neoplasms
    290 rdf:type schema:DefinedTerm
    291 Nff8315903ac34cbfada8510730c233ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    292 schema:name Apoptosis Regulatory Proteins
    293 rdf:type schema:DefinedTerm
    294 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    295 schema:name Medical and Health Sciences
    296 rdf:type schema:DefinedTerm
    297 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    298 schema:name Clinical Sciences
    299 rdf:type schema:DefinedTerm
    300 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    301 schema:name Oncology and Carcinogenesis
    302 rdf:type schema:DefinedTerm
    303 sg:grant.2472689 http://pending.schema.org/fundedItem sg:pub.10.1186/bcr3153
    304 rdf:type schema:MonetaryGrant
    305 sg:grant.2478808 http://pending.schema.org/fundedItem sg:pub.10.1186/bcr3153
    306 rdf:type schema:MonetaryGrant
    307 sg:journal.1022375 schema:issn 1465-5411
    308 1465-542X
    309 schema:name Breast Cancer Research
    310 schema:publisher Springer Nature
    311 rdf:type schema:Periodical
    312 sg:person.01004662215.12 schema:affiliation grid-institutes:grid.410427.4
    313 schema:familyName Schoenlein
    314 schema:givenName Patricia Veronica
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004662215.12
    316 rdf:type schema:Person
    317 sg:person.01337003046.60 schema:affiliation grid-institutes:grid.410427.4
    318 schema:familyName Jackson
    319 schema:givenName William Hutch
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337003046.60
    321 rdf:type schema:Person
    322 sg:person.013746210127.32 schema:affiliation grid-institutes:grid.410427.4
    323 schema:familyName Thangaraju
    324 schema:givenName Muthusamy
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013746210127.32
    326 rdf:type schema:Person
    327 sg:person.016241417173.08 schema:affiliation grid-institutes:grid.410427.4
    328 schema:familyName Takhar
    329 schema:givenName Suchreet
    330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016241417173.08
    331 rdf:type schema:Person
    332 sg:person.0625462470.10 schema:affiliation grid-institutes:grid.410427.4
    333 schema:familyName Huang
    334 schema:givenName Shuang
    335 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625462470.10
    336 rdf:type schema:Person
    337 sg:person.0655015541.06 schema:affiliation grid-institutes:grid.410427.4
    338 schema:familyName Marrero
    339 schema:givenName Mario
    340 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655015541.06
    341 rdf:type schema:Person
    342 sg:person.0700722655.45 schema:affiliation grid-institutes:grid.152326.1
    343 schema:familyName Dohn
    344 schema:givenName Michael Robert
    345 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700722655.45
    346 rdf:type schema:Person
    347 sg:person.0756555441.09 schema:affiliation grid-institutes:grid.59734.3c
    348 schema:familyName LeRoith
    349 schema:givenName Derek
    350 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756555441.09
    351 rdf:type schema:Person
    352 sg:person.0774235463.53 schema:affiliation grid-institutes:grid.410427.4
    353 schema:familyName Periyasamy-Thandavan
    354 schema:givenName Sudharsan
    355 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774235463.53
    356 rdf:type schema:Person
    357 sg:pub.10.1007/978-0-387-74039-3_10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042360122
    358 https://doi.org/10.1007/978-0-387-74039-3_10
    359 rdf:type schema:CreativeWork
    360 sg:pub.10.1007/s10549-005-4794-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035294705
    361 https://doi.org/10.1007/s10549-005-4794-6
    362 rdf:type schema:CreativeWork
    363 sg:pub.10.1023/a:1006078032287 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047082193
    364 https://doi.org/10.1023/a:1006078032287
    365 rdf:type schema:CreativeWork
    366 sg:pub.10.1023/a:1006098910000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035756397
    367 https://doi.org/10.1023/a:1006098910000
    368 rdf:type schema:CreativeWork
    369 sg:pub.10.1023/a:1016249728664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042256597
    370 https://doi.org/10.1023/a:1016249728664
    371 rdf:type schema:CreativeWork
    372 sg:pub.10.1038/cdd.2008.148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043432644
    373 https://doi.org/10.1038/cdd.2008.148
    374 rdf:type schema:CreativeWork
    375 sg:pub.10.1038/cdd.2010.41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042843410
    376 https://doi.org/10.1038/cdd.2010.41
    377 rdf:type schema:CreativeWork
    378 sg:pub.10.1038/nrc2713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018166274
    379 https://doi.org/10.1038/nrc2713
    380 rdf:type schema:CreativeWork
    381 sg:pub.10.1038/onc.2011.36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011840580
    382 https://doi.org/10.1038/onc.2011.36
    383 rdf:type schema:CreativeWork
    384 sg:pub.10.1038/sj.gt.3301897 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001467529
    385 https://doi.org/10.1038/sj.gt.3301897
    386 rdf:type schema:CreativeWork
    387 sg:pub.10.1038/sj.onc.1204963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018294528
    388 https://doi.org/10.1038/sj.onc.1204963
    389 rdf:type schema:CreativeWork
    390 sg:pub.10.1038/sj.onc.1205506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011228248
    391 https://doi.org/10.1038/sj.onc.1205506
    392 rdf:type schema:CreativeWork
    393 sg:pub.10.1186/bcr2361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040461259
    394 https://doi.org/10.1186/bcr2361
    395 rdf:type schema:CreativeWork
    396 sg:pub.10.1186/bcr3040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044719011
    397 https://doi.org/10.1186/bcr3040
    398 rdf:type schema:CreativeWork
    399 grid-institutes:grid.152326.1 schema:alternateName Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA
    400 schema:name Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA
    401 rdf:type schema:Organization
    402 grid-institutes:grid.410427.4 schema:alternateName Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    403 Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    404 Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA
    405 schema:name Department of Biochemistry, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    406 Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    407 Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    408 Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA
    409 rdf:type schema:Organization
    410 grid-institutes:grid.59734.3c schema:alternateName Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA
    411 schema:name Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA
    412 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...